In its annual report, TFAH said there are still major gaps and funding needed to battle new threats.
US flu activity increased slightly again last week, reflecting a season that's off to a slower start compared with the previous year, according to the latest data today from the Centers for Disease Control and Prevention (CDC).
As part of an ongoing effort to weigh different vaccine strategies against H7N9 avian influenza, researchers today reported results from a small clinical trial that showed promise for a prime-boost strategy.
A research team led by the National Institute of Allergy and Infectious Diseases (NIAID) reported the findings in the Journal of Infectious Diseases.
A live attenuated influenza vaccine (LAIV) candidate for H7N9 avian flu produced a good immune response and was shown safe in a phase 1 human trial, researchers from Russia and the World Health Organization (WHO) reported yesterday in The Lancet Infectious Diseases.
Evidence didn't support routine use for seasonal flu, and the group said research is needed during epidemics.
NewLink Genetics today announced that the federal government has exercised an $18 million option to ramp up the production of its experimental Ebola vaccine VSV-EBOV, according to a statement from the company. The company has licensed the vaccine from the Public Health Agency of Canada, the developer of the vaccine, which is furthest along in clinical studies in the West African outbreak region.
The Department of Health and Human Services (HHS) is funding two projects to aid in developing better seasonal flu vaccines and in improving pandemic flu preparedness, the agency said in a news release yesterday.
Both the H3N2 and B strains will differ in next year's Southern Hemisphere trivalent flu vaccine.
Bipartisan leaders of the US House oversight and investigations subcommittee yesterday continued to press federal health officials for answers about seasonal flu preparedness in the wake of a mismatch between the vaccine and the main circulating strain last season.
BARDA's director says he's hopeful that a call for proposals in October will bear better fruit.
